Debayan Mukherjee
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1.
Journal: Oncoimmunology
Published: June 19, 2023
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy.
Journal: Frontiers in immunology
Published: February 06, 2023
Radiotherapy transiently reduces the sensitivity of cancer cells to lymphocyte cytotoxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 07, 2021
The effect of hypoxia on PD-L1 expression in bladder cancer.
Journal: BMC cancer
Published: May 19, 2021
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer.
Journal: Cancers
Published: August 17, 2020
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment.
Journal: EMBO molecular medicine
Published: November 01, 2017
Responses to ionizing radiation mediated by inflammatory mechanisms.
Journal: The Journal of pathology
Published: September 26, 2013
Radiation-induced bone marrow apoptosis, inflammatory bystander-type signaling and tissue cytotoxicity.
Journal: International journal of radiation biology
Published: October 20, 2012
The in vivo expression of radiation-induced chromosomal instability has an inflammatory mechanism.
Journal: Radiation research
Published: November 05, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026